IDB HOLDING INVESTS IN LAB EVO, A START-UP FOR DIGITIZATION IN THE HEALTH SECTORTHE GROUP, TO WHICH INDENA S.P.A. AND SCHARPER S.P.A. BOTH BELONG,CONFIRMS ITS ATTENTION DEVOTED TO INNOVATIVE SOLUTIONS FOR PEOPLE’S HEALTH
Milan, 18th October 2023 – Lab Evo S.r.l, an innovative start-up for digitization in the health sector, isdelighted to announce the entrance into its share capital of IDB Holding S.p.A., the holding company of theGroup that includes Indena S.p.A., a leading company in the identification, development and production ofhigh-end active botanical principles for the pharmaceutical and nutraceutical industry, and Scharper S.p.A., apharmaceutical company active in the development and marketing of medicinal specialities, food supplements
and medical devices used to improve people’s health and wellbeing.
The investment operation by IDB Holding is intended to further support the development and expansion of Lab
Evo and its interesting project in the important direction of digitization in the health sector.
Lab Evo is taking up this challenge by providing an innovative and safe alternative to traditional laboratory
analyses. In fact, thanks to easy-to-use, self-explanatory kits, customers can provide specimens independently
and conveniently in their own homes, as well as at the pharmacy or the office, thanks to the collaborations thatLab Evo has set up with a number of chains of pharmacies and companies with the aim of disseminating thevalue of prevention. After using the analysis kits provided by Lab Evo, customers send the samples to thepartner laboratories spread across the entire Italian territory and the results are processed quickly andaccurately through the use of advanced analysis technologies, enabling prompt and precise responses.
The involvement of IDB Holding will allow the further development of the platform and the services provided
by Lab Evo, envisaging, among other things, the offer of personalized nutraceutical solutions following theresults of the laboratory analyses. Thanks to intelligent algorithms and the use of customers’ medical data, theplatform is in fact capable of suggesting specific treatments and providing indications to improve their lifestyleand to keep the key health check parameters monitored. Furthermore, through appropriate channels, thecustomers concerned will be able to interact with qualified physicians by means of examinations via video link,enabling immediate and professional consultations.
“IDB Holding follows new initiatives and technologies that can contribute to improving people’s health withgreat interest, and believes in the development of home diagnostics - says Daniele Giavini, Managing Directorof Indena S.p.A. and Board Member of IdB Holding S.p.A. -. Supporting Lab Evo means creating a synergy
between a service that makes the management of diagnostic examinations and the offer of high-quality natural
products for health checks for the public easier. For a very long time both Indena, with its excellent active
botanical principles, and Scharper, with its offer of high-end supplements, have worked to provide effective
support for people’s wellbeing and health, combining nature and science”.
The increase in capital recently concluded represents a significant milestone for Lab Evo. The funds madeavailable will be used to further improve the platform, to expand geographical coverage and to invest in
research and development activities with a view to new functionalities. Lab Evo is aiming to become the pointof reference for remote access to laboratory analyses and to personalized solutions, offering a high-quality,safe and efficient service. The involvement of IDB Holding can also allow the development of partnerships andcommercial collaborations between Lab Evo and the other companies and customers of the IDB Group.
"This increase in capital represents an important recognition of the value of our company and its potential for
impact in the health sector" - affirms Lab Evo CEO Matteo Nobili -. We are enthusiastic about being able tocollaborate with the IDB Holding Group, our new partner to speed up our growth and to take our innovation toan ever wider public".

Lab Evo continues to receive both positive reviews from users and a high level of interest on the part ofprofessionals in the sector. Thanks to its unique combination of avant-garde technology and quality services,
Lab Evo is redefining the way in which the people access laboratory analyses and receive personalizedsolutions.

For further information
IDB Holding
BCW-Burson Cohn & Wolfe
Luisa Cavagnera: luisa.cavagnera@bcw-global.com Ph: +39.349.7665890
LabEvoMatteo Nobili: mn@lab-evo.com Ph: +39.340.2167158